𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma

✍ Scribed by Kyle Rusthoven; Ari Ballonoff; David Raben; Changhu Chen


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
145 KB
Volume
112
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

The objective of this study was to compare survival in patients with squamous cell carcinoma (SCC) of the oral tongue with that in patients with SCC in other oral cavity subsites.

METHODS

Patients with stage I and II (T1‐T2N0M0) SCC of the oral cavity diagnosed between 1988 and 2004 were queried by using the Surveillance, Epidemiology, and End Results (SEER) database. The log‐rank test was used to compare the overall survival (OS) and cause‐specific survival (CSS) of patients who had oral tongue SCC with those of patients who had SCC of other oral cavity subsites. A Cox proportional hazards multivariate analysis was performed to evaluate the influence of covariates on the risk of CSS and OS.

RESULTS

Between 1988 and 2004, 6791 patients with stage I and II SCC of the oral cavity were identified. Among them, 40% had oral tongue SCC, and 60% had SCC of other oral cavity subsites. The median patient age was 64 years. The 5‐year OS and CSS rates were 60.9% and 83.5%, respectively, for patients with oral tongue SCC versus 64.7% and 94.1%, respectively, for patients with SCC of other oral cavity subsites (OS: hazard ratio, 1.24; P < .0001; CSS: hazard ratio, 3.04; P < .0001). On multivariate analysis, OS and CSS were influenced significantly by T classification, age, sex, and oral tongue subsite. The CSS for patients who had stage I and II oral tongue SCC also was unfavorable compared with the CSS for stage‐matched patients who had SCC of other head and neck sites.

CONCLUSIONS

Oral tongue SCC was associated with poor survival compared with other oral cavity and head and neck sites. These data suggested a potential benefit for multimodality therapy in this cohort of patients. Cancer 2008. Β© 2007 American Cancer Society.


πŸ“œ SIMILAR VOLUMES


Low p27 expression correlates with poor
✍ Hiroyuki Mineta; Katsutoshi Miura; Ikuko Suzuki; Satoru Takebayashi; Hajime Aman πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 2 views

## Background: P27, a cyclin-dependent kinase inhibitor, regulates progression from g1 to s phase. there have been a few clinical reports of low p27 expression associated with poor survival among patients with cancer; however, there have been no reports of such an association in cases of head and n

EphA2 overexpression correlates with poo
✍ Tatsuya Miyazaki; Hiroyuki Kato; Minoru Fukuchi; Masanobu Nakajima; Hiroyuki Kuw πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 370 KB πŸ‘ 1 views

## Abstract EphA2 is a member of the Eph family of receptor tyrosine kinases, which interact with cell‐bound ligands known as ephrins. EphA2 expression was investigated by immunohistochemistry with an anti‐EphA2 monoclonal antibody in 80 patients with esophageal squamous cell carcinoma (ESCC) who h

Hypercalcemia related to the poor progno
✍ Dr. Hiroyuki Kuwano; Hideo Baba; Hiroyuki Matsuda; Shinji Ohno; Masaki Mori; Tak πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 362 KB

A review of 208 cases of surgically treated squamous cell carcinoma of the esophagus revealed 16 (7.7%) with hypercalcemia. There was no evidence of bone metastases in 13 (6.3%) of the patients with hypercalcemia. Pathogenesis of this hypercalcemia without bone metastases was suggested to be multifa

Human leukocyte antigen-G expression is
✍ Aifen Lin; Xia Zhang; Wen-Jun Zhou; Yan-Yun Ruan; Dan-Ping Xu; Qing Wang; Wei-Hu πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 485 KB πŸ‘ 1 views

## Abstract Human leukocyte antigen **(**HLA)‐G inhibits functions of immune component cells and promotes malignant cells evading from antitumor immunity. We investigated the clinical relevance of HLA‐G expression in esophageal squamous cell carcinoma (ESCC). In our study, HLA‐G expression in 79 pr